Table of Contents
AI Summary:
A Salmonella Typhi and Paratyphi Antigen Rapid Test detects bacterial antigens directly in a fecal specimen, while antibody based methods such as the Widal test detect the body’s immune response to Salmonella. Molecular testing and blood culture provide additional diagnostic approaches, each with different specimen, infrastructure and interpretation requirements. No single method is universally better. The appropriate choice depends on the diagnostic objective, specimen availability, turnaround requirements, laboratory resources and whether additional testing is needed. This article compares these approaches, including the documented performance and limitations of the iCARE antigen rapid test.
Why Antigen and Antibody Testing Answer Different Diagnostic Questions
Typhoid and paratyphoid fever are caused by Salmonella Typhi and Salmonella Paratyphi, and interpreting a test result depends on which biological marker that test is designed to find. A Salmonella Typhi and Paratyphi Antigen Rapid Test looks for bacterial antigens in a stool sample, while an antibody based method such as the Widal test detects the immune response to Salmonella. These are different diagnostic questions, and treating them as interchangeable leads to misinterpreted results.
Laboratories, hospitals, government health programs and NGOs evaluating typhoid diagnostic options need to understand what each test measures, where it fits into a diagnostic pathway, and how a typhoid antigen vs antibody test choice, including a Widal vs antigen test decision, actually plays out in practice.
Email Us Today!
What Is Typhoid Diagnosis and What Do Different Tests Detect?
Diagnostic testing for typhoid exists to answer one core question: is Salmonella Typhi or Paratyphi present, or has the immune system already responded to it. Four broad categories of methods are used to answer that question.
- Antigen detection identifies bacterial proteins or surface components directly in a patient specimen, most commonly feces.
- Antibody detection identifies immunoglobulins the body has produced against the bacteria, typically from a blood sample.
- Molecular testing (PCR) identifies bacterial genetic material.
- Blood culture attempts to grow and isolate viable bacteria from a patient sample.
Each category is explored in its own section below, so this overview is intentionally brief. The point worth carrying forward is that a positive result from one category does not mean the same thing as a positive result from another.
What Is a Salmonella Typhi and Paratyphi Antigen Rapid Test?
The iCARE Salmonella Typhi/Paratyphi Antigen Rapid Test is a qualitative, lateral flow immunoassay intended to aid in detecting S. Typhi and Paratyphi (types A, B and C) antigens in human fecal specimens. It is intended for professional in vitro diagnostic use and is designed to provide preliminary results rather than function as a standalone diagnostic criterion.
The test combines a monoclonal antibody colloidal gold conjugate with a polyclonal antibody to qualitatively identify S. Typhi and/or Paratyphi antigens in a stool sample. Because the sample type is feces rather than blood, collection does not require venipuncture, which can simplify testing in field and outpatient settings.
How Does a Salmonella Typhi and Paratyphi Antigen Rapid Test Work?
The underlying principle is lateral flow immunochromatography. The test membrane is pre coated with anti Salmonella antibodies in the test line region. When an extracted fecal specimen is applied, it mixes with a particle conjugated antibody and migrates across the membrane by capillary action.
If Typhi or Paratyphi antigens are present in the specimen, they bind to the antibodies coating the membrane and generate a visible colored line in the test region, however faint, which is read as positive. If antigens are absent, no line forms in that region, and the sample is read as negative.
A separate line appears in the control region. The control line indicates that the test has produced the required procedural control response, meaning sufficient specimen volume moved through the strip, regardless of whether a test line appears. If the control line does not appear within the reading window, the result is considered invalid and the test needs to be repeated using a new device rather than interpreted as either positive or negative.
What Does a Typhoid Antibody Test Measure?
Antibody based testing, most familiar through the Widal test, measures the host immune response rather than the organism itself. Antibody levels typically rise gradually after exposure, which introduces interpretation challenges that antigen detection does not share.
Because antibody levels can be influenced by prior exposure, endemic background immunity, vaccination history or cross reaction with related organisms, a single antibody reading is generally harder to interpret in isolation than a direct antigen finding. Titer patterns, paired samples or comparison against a locally established baseline are often needed to make sense of a result. This resource does not introduce specific sensitivity or specificity figures for antibody based methods, since none are being drawn from an approved source for that comparison.
Typhoid Antigen vs Antibody Test: What Is the Difference?
| Factor | Antigen Test | Antibody Test |
| What is detected | Bacterial antigen | Host produced antibody |
| Biological target | Components associated with S. Typhi/Paratyphi | Immune response to prior or current exposure |
| Specimen | Human fecal specimen (for the iCARE rapid test) | Typically blood or serum |
| Diagnostic purpose | Preliminary detection of Salmonella Typhi or Paratyphi antigens | Assessment of an immune response, interpreted with clinical context |
| Interpretation | Presence of any test line indicates a positive result; intensity is not quantitative | Requires consideration of titer patterns and clinical history |
| Timing considerations | Most useful when antigen is present in the specimen at collection | Antibody levels can take time to develop and may persist after exposure |
| Confirmation | May need to be paired with an alternative method depending on clinical suspicion | Often interpreted alongside additional testing and clinical findings |
Each row reflects a specific operational or interpretive difference rather than a ranking of accuracy.
Widal vs Antigen Test: Why Titers Complicate Interpretation
A Widal vs antigen test question usually comes down to one practical issue: Widal results are titers, not a simple positive or negative reading. A single titer value can be difficult to interpret without a paired sample, a locally established baseline, or knowledge of the patient’s prior exposure and vaccination history, since background antibody levels vary across populations in endemic regions.
An antigen rapid test avoids this particular interpretation problem because it reports a qualitative result rather than a titer. That does not make it a direct substitute for Widal testing in every workflow; it simply means the two methods carry different interpretation demands. A raised Widal titer should not automatically be treated as equivalent to a positive antigen finding, and a laboratory moving between the two methods should account for that difference rather than assume one score maps onto the other.
In practice, this means a facility relying on Widal testing may need locally established cutoff titers or paired acute and convalescent samples to draw a confident conclusion, while a facility using an antigen rapid test is working with a single qualitative readout that does not require that comparative step.
Antigen Test vs PCR for Typhoid Diagnosis
Polymerase chain reaction testing identifies Salmonella genetic material rather than intact antigens, using specimens that may include blood, stool or other clinical samples depending on the assay and laboratory protocol in use. Running PCR generally requires validated reagents, calibrated thermal cycling equipment and staff trained in molecular technique, which places it firmly within a laboratory setting rather than a bedside or field workflow.
Turnaround time for PCR depends on the specific platform, batching practices and how the laboratory is staffed, and can range from same day to a longer processing window depending on local workflow. Molecular confirmation tends to be most useful when a case needs a highly specific answer, for instance when a negative antigen result does not match persistent clinical suspicion, or when a facility needs to characterize an outbreak strain rather than simply screen individual patients.
Antigen Test vs Blood Culture for Typhoid Diagnosis
Blood culture’s distinguishing strength is what happens after a positive result: when Salmonella is successfully isolated and grown, the recovered organism can be tested directly for antimicrobial susceptibility, giving clinicians information about which antibiotics are likely to be effective for that specific case. Neither an antigen rapid test nor PCR provides this, since both detect a marker of the organism rather than recovering it as a living culture.
That susceptibility information becomes particularly relevant where antimicrobial resistance patterns are a known concern, or where empirical treatment has not produced an expected clinical response. An antigen rapid test remains a reasonable first step for preliminary screening, with blood culture reserved for cases where isolating the organism itself adds clinical value beyond confirming its presence.
When Can a Typhoid Antigen Test Be Considered?
Institutions evaluating whether an antigen based rapid test fits their diagnostic workflow typically weigh several practical factors. Hospitals, laboratories and NGOs sourcing through a typhoid rapid test kit manufacturer or a typhoid rapid test kit supplier generally start from these same factors before comparing specific products.
- Specimen availability: a fecal specimen must be collected properly, avoiding excess stool that could block the specimen well or produce an invalid result.
- Testing workflow: settings without laboratory infrastructure may value a test that requires no equipment and produces a result within twenty minutes.
- Rapid preliminary information: settings such as field clinics or outbreak response programs may place greater importance on short turnaround times when evaluating diagnostic workflows.
- Laboratory resources: facilities with access to PCR or culture may use the antigen test as an initial step ahead of confirmatory testing.
- Clinical findings: signs, symptoms and patient history remain part of how any result should be interpreted.
Accuracy and Performance of the Salmonella Typhi and Paratyphi Antigen Rapid Test
The iCARE Salmonella Typhi/Paratyphi Antigen Rapid Test has been evaluated against a reference commercial RT PCR assay using clinical fecal samples from symptomatic, culture positive patients during the first week of illness.
| Pathogen | Sensitivity (Positive Percent Agreement) | Specificity (Negative Percent Agreement) | Accuracy (Overall Percent Agreement) |
| S. Typhi | 98.03% | 99.50% | 99.00% |
| Paratyphi | 98.00% | 99.54% | 99.25% |
In cross reactivity evaluation, the test showed no reactivity against Rotavirus, Adenovirus, H. Pylori or spiked Cholera specimens, and correctly distinguished between typhoid fever and paratyphoid specimens in the panel tested.
These figures are reported evaluation results under the stated study conditions and should not be read as guaranteed outcomes under every testing circumstance. They do not remove the need for clinical judgment or, where appropriate, confirmatory testing.
Limitations of Antigen Based Typhoid Testing
Any antigen rapid test carries defined limitations that affect how results should be used, and these apply directly to the iCARE Salmonella Typhi/Paratyphi Antigen Rapid Test.
- The test provides qualitative results only; it does not report a specific antigen titer, and test line intensity does not correlate linearly with the amount of antigen present.
- The test should not be used as the sole criterion for diagnosing S. Typhi or Paratyphi infection.
- A negative result can occur when antigen levels fall below the test’s detection capability, or when antigen presence varies by the stage of illness at which the sample was collected.
- A negative result does not fully exclude the possibility of exposure to or infection with S. Typhi or Paratyphi.
- The test cannot determine which specific Paratyphi serotype, among A, B or C, is present in a specimen.
- When symptoms are suspicious or persist despite a negative result, additional testing using an alternative clinical method, such as PCR or blood culture, is recommended.
- Results should always be interpreted alongside other diagnostic procedures and relevant clinical findings.
These limitations reflect the nature of antigen based lateral flow methodology in general and should inform how any facility incorporates this type of test into a broader diagnostic pathway.
Which Typhoid Diagnostic Method Is Better?
The appropriate method depends on what a laboratory or clinician is actually trying to determine, and procurement teams working with a typhoid test kit manufacturer or typhoid test kit supplier will typically apply the same reasoning when comparing antigen, antibody and molecular options.
| Decision Factor | What to Consider |
| Detection target | Whether the priority is antigen, antibody, genetic material or a viable organism |
| Specimen | What specimen type is realistically available, such as feces or blood |
| Testing purpose | Whether the goal is preliminary detection, confirmation or another diagnostic objective |
| Turnaround | How quickly a result is needed to guide clinical decisions |
| Infrastructure | What laboratory equipment and trained personnel are actually available on site |
| Interpretation | How the result will be weighed alongside other findings and patient history |
| Confirmation | Whether a positive or negative result will need to be verified through another method |
| Procurement | Packaging, storage conditions, workflow fit and institutional purchasing requirements |
A Salmonella Typhi and Paratyphi Antigen Rapid Test may be considered when a facility needs preliminary antigen detection from a fecal specimen within a short testing workflow. The Widal test may still have a place where antibody information is relevant to the clinical picture. PCR and blood culture remain important where confirmation, genetic specificity or organism isolation is required. No single diagnostic method should automatically be treated as the correct choice for every situation; the framework above is intended to guide that evaluation rather than replace it.
Choosing a Typhoid Rapid Test Kit Manufacturer or Supplier
Institutions moving from method selection to procurement generally look for a typhoid rapid test kit manufacturer or typhoid rapid test kit supplier that can document performance data, offer flexible pack sizes, and support storage and transport conditions that fit their setting. Consistency across production lots and clear regulatory documentation also matter for facilities that need to justify a purchasing decision to a procurement board or funding body.
JAL Medical, based in Singapore, identifies itself as a manufacturer and supplier of the iCARE Salmonella Typhi/Paratyphi Antigen Rapid Test referenced throughout this comparison. The kit’s documented performance was evaluated against a reference RT PCR assay, and it is offered in pack sizes suited to both pilot orders and larger institutional supply. JAL Medical also offers antibody based formats such as a Typhoid IgG+IgM Test Kit, which addresses a different diagnostic target from a fecal antigen test and may be relevant to institutions evaluating both approaches side by side.
Call Us Now!
Conclusion
Choosing between antigen, antibody, molecular and culture based typhoid testing comes down to matching the method to the diagnostic question at hand rather than assuming one approach is universally correct. The decision factors outlined above, detection target, specimen availability, testing purpose, turnaround time, infrastructure and the likelihood of needing confirmation, apply whether an institution is comparing a Salmonella Typhi and Paratyphi Antigen Rapid Test against Widal testing, PCR or blood culture, or evaluating offers from different suppliers.
Frequently Asked Questions
What is a Salmonella Typhi and Paratyphi Antigen Rapid Test?
It is a qualitative lateral flow immunoassay designed to detect S. Typhi and Paratyphi (types A, B and C) antigens in human fecal specimens. It is intended for professional in vitro diagnostic use and provides preliminary results that should be confirmed with an alternative testing method and clinical findings, based on the judgment of a healthcare provider.
What specimen is used for the iCARE Salmonella Typhi and Paratyphi Antigen Rapid Test?
The test uses a human fecal specimen. A random stool sample is collected, extracted using the provided specimen collection tube and buffer, and then applied to the test device for reading.
How quickly can results be read with the iCARE rapid test?
Results are read at 15 to 20 minutes after the specimen is applied. Positive results may become visible as early as 1 minute, but negative results must be confirmed only at the end of the full 20 minute window, and results should not be interpreted after that time.
How is a positive result interpreted on this test?
A positive result is indicated by a colored line appearing in the test line region alongside the control line. The intensity of the test line does not correlate with how much antigen is present, so any visible line, however faint, within the reading window is read as positive.
What can cause an invalid result in an antigen rapid test?
An invalid result occurs when the control line fails to appear within the reading window, most often due to insufficient specimen volume or incorrect procedural technique. The test should be repeated with a new device, and if the issue persists, testing should stop and the distributor should be contacted.
Can a negative antigen test completely exclude typhoid infection?
No. A negative result means that Salmonella Typhi or Paratyphi antigen was not detected in the tested specimen. If clinical suspicion remains, additional diagnostic evaluation may be appropriate.
Can this test identify which Paratyphi serotype is present?
No. The test detects Paratyphi antigens across types A, B and C collectively but cannot determine which specific serotype is present in a given specimen. Serotype identification, where clinically relevant, typically requires culture based methods.
Does performing this test require laboratory equipment?
No. The test is designed for a rapid testing workflow that does not require laboratory equipment, electricity or refrigeration at the testing site itself, though the kit should be stored within its specified temperature range before use.
Is an antigen test better than a Widal test for typhoid?
Neither is universally better. An antigen test reports a qualitative result and is designed for a simpler workflow, while a Widal test produces a titer that often needs a paired sample or a locally established baseline to interpret. Which is more appropriate depends on the specimen available and how the result will be used.
What is the difference between a Typhoid IgG+IgM Test Kit and an antigen test?
A Typhoid IgG+IgM Test Kit detects antibodies the immune system has produced against Salmonella, typically from blood, while an antigen test such as the Salmonella Typhi and Paratyphi Antigen Rapid Test detects bacterial antigen directly from a fecal specimen. The two address different diagnostic questions rather than one replacing the other.
When is blood culture preferred over a rapid typhoid test?
Blood culture is generally preferred when a confirmed, culturable isolate is needed, such as for antimicrobial susceptibility testing, or when a definitive diagnosis is required beyond a preliminary screening result. A rapid antigen test is more suited to settings that need a faster result without laboratory infrastructure.
